CTOs on the Move

Babson Diagnostics

www.babsondx.com

 
Babson Diagnostics is bringing medically-accurate blood testing to the pharmacy, and empowering people to take charge of their health by reimagining the entire blood testing process from ordering, collection, handling, analyzing, and reporting of results, making it less invasive and more convenient, accessible, and patient-centered.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.babsondx.com
  • 1205 Sheldon Cove Suite 2-J
    Austin, TX USA 78753
  • Phone: 512.562.2473

Executives

Name Title Contact Details

Funding

Babson Diagnostics raised $13.7M on 09/24/2020
Babson Diagnostics raised $31M on 06/29/2021

Similar Companies

CJW Medical Center

We are experts in the field, along the sidelines and in locker rooms. We have Richmond's only outdoor assessment field used for testing athletes in simulated game conditions with dedicated areas for soccer, basketball, tennis, track, plus a pitcher's

Healthways

Healthways, a Sharecare company, is a global provider of well-being improvement solutions. Dedicated to creating a healthier world one person at a time, the company uses the science of behavior change to produce and measure positive change in well-being for our customers, which include employers, integrated health systems, hospitals, physicians, health plans, communities and government entities.

West Hills Health and Rehabilitation Center

West Hills Health and Rehabilitation Center is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sanbor Medical

Sanbor Medical is a Allentown, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarepta

Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.